Table 1.
Laboratory characteristics of the patient with ESKD infected with COVID-19
| Feb 11 | Feb 13 | Feb 15 | Feb 16 | Feb 17 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|
| White blood cells, ×109 per L | 7.2 | 6.8 | 6 | 6.3 | 6.7 | 7.4 | 7.4 | 5.9 | 6 |
| Neutrophil count, ×109 per L | 6.41 | 6.03 | 5.2 | 5.47 | 5.52 | 6.05 | 5.95 | 4.86 | 4.72 |
| Lymphocyte count, ×109 per L | 0.28 | 0.27 | 0.35 | 0.42 | 0.46 | 0.61 | 0.87 | 0.46 | 0.69 |
| C-reactive protein, mg/L | 200.18 | 192.44 | 119.16 | 92.34 | 70.48 | 40.56 | 24.06 | 14.23 | 13.04 |
| Fibrinogen, g/L | 5.22 | 4.22 | 4.85 | 3.74 | 3.53 | 3.44 | 3.69 | 3.58 | 3.38 |
| D-dimer, mg/L | 3.51 | 4.75 | 3.6 | 3.42 | 2.93 | 3.99 | 3.07 | 2.45 | |
| BUN, mmol/L | 40 | 36.34 | 29.49 | 29.45 | 31.38 | 39.47 | 38.51 | 36.7 | 33.82 |
| Cr, μmol/L | 1,432.3 | 1,084.7 | 873.1 | 820.2 | 886 | 1,091.1 | 902 | 1,037 | 924.6 |
| Uric acid, μmol/L | 760 | 489 | 359 | 320 | 351 | 440 | 421 | 382 | 349 |
| Cystatin C, mg/L | 8 | 4.62 | 4.53 | 2.79 | 5.46 | 6.13 | 5.99 | 4.34 | 4.64 |
| Brain natriuretic peptide, pg/mL | 13,254 | 8,759 | 2,203 | 1,034 | 1,200 | 231 | 243 | 270 | 253 |
ESKD, end-stage kidney disease; COVID-19, coronavirus disease 2019.